ArticleJCEM case reports2026
Normo-hormonal primary hyperparathyroidism presenting with recurrent acute pancreatitis.
Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary hyperparathyroidism is an endocrine disorder with diverse clinical and biochemical manifestations. Albright classically described the condition as a disease of "stones, bones, groans, and moans." Its clinical spectrum may include recurrent acute pancreatitis secondary to hypercalcemia. Although biochemically the disorder typically presents with elevated serum calcium, reduced serum phosphate, and increased parathyroid hormone (PTH) levels, atypical manifestations are possible. We report the case of a 41-year-old man who presented with recurrent episodes of acute pancreatitis and on evaluation was found to have persistently elevated serum calcium and low serum phosphorus levels with intact PTH (iPTH) concentrations within the laboratory reference range. In the context of hypercalcemia, a normal PTH level was considered inappropriately normal because physiologic feedback would typically suppress PTH secretion. Consequently, normo-hormonal primary hyperparathyroidism (NHpHPT) was suspected, and localization workup undertaken. Dual-phase technetium
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.